@misc{indiciae114f55a9732e,
  title = {Efficacy and Safety of iGlarLixi Versus IDegAsp by Baseline Age, Disease Duration and HbA1c in Chinese People With Type 2 Diabetes: Post Hoc Analyses of the Soli-D Study.},
  author = {Saichun Zhang and Yunjuan Gu and Yu Cheng and Ying Hu and Bing Li and Agustina Alvarez and Felipe Lauand and Lydie Melas-Melt and Minlu Zhang and Yini Jiang and Qin Du and Lei Kang and Yiming Mu and Weijun Gu and Hongyu Kuang},
  year = {2026},
  doi = {10.1111/dom.71057},
  url = {https://pubmed.ncbi.nlm.nih.gov/42473266/},
  note = {Source identifier: 42473266}
}